Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Fenofibrate (Primary) ; Niacin/laropiprant (Primary) ; Rosuvastatin (Primary) ; Atorvastatin; Simvastatin
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 09 Aug 2011 Planned End Date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 17 Nov 2009 New trial record